Wegovy and green tea: what the evidence actually shows

What the clinical evidence actually says about semaglutide and green tea

There are no head-to-head randomised trials examining whether green tea enhances, diminishes or alters the outcomes of semaglutide treatment. That absence is itself informative. The results seen in the STEP 1 trial (published in the New England Journal of Medicine) showed around 15% average body-weight loss over 68 weeks using semaglutide 2.4mg alongside a calorie-reduced diet and increased activity. No supplementary beverage was part of the protocol. The weight lost in that trial came from the medicine working on GLP-1 receptors in the brain and gut, slowing gastric emptying and reducing appetite, a mechanism quite separate from anything green tea does.

Green tea contains catechins, most notably epigallocatechin gallate (EGCG), and a moderate amount of caffeine. A number of small studies have looked at green tea extract and modest changes in metabolic rate or fat oxidation, but the effect sizes are small, the studies short, and the findings inconsistent. Adding green tea to a Wegovy regimen is unlikely to produce any meaningful additive weight-loss benefit beyond what the medicine and lifestyle changes already deliver.

For a broader look at how different teas interact with semaglutide treatment and how the medicine works, our page on semaglutide and tea covers the topic across drink types.

The gastric-emptying effect: why caffeine timing matters slightly more on Wegovy

Wegovy slows gastric emptying. That is part of how it keeps you feeling full for longer. The practical consequence, which a question our prescribers hear most weeks, is whether drinks containing caffeine (including green tea) feel stronger or last longer on Wegovy than they did before.

The answer is: possibly, for some people. If gastric emptying slows, caffeine from food or drink may be absorbed more gradually. Whether that produces noticeable effects depends heavily on individual tolerance. Some patients report feeling caffeine more acutely in the first weeks of treatment or after a dose increase; others notice nothing. This is not a contraindication, it is a physiological nuance worth being aware of.

If you find green tea triggers nausea, that is more likely a function of Wegovy's GI side-effect profile (nausea, indigestion and reflux are among the common ones listed in the NHS semaglutide medicines page) than anything specific to green tea itself. Drinking it between meals rather than immediately before or after eating tends to be better tolerated during the adjustment period.

More on how Wegovy affects the body is covered on our Wegovy treatment overview.

What green tea genuinely offers during a weight-loss programme

Setting aside the overstated supplement claims, green tea is a low-calorie, hydrating drink and a reasonable choice during a calorie-reduced programme. Staying well hydrated supports the body during the GI adjustment that many patients experience at the start of treatment. Replacing sugary drinks with green tea reduces caloric intake in a small but real way, useful context given that the lifestyle component of Wegovy treatment (diet and increased activity) runs alongside the medicine, not separately from it.

Green tea is not a substitute for that structured dietary effort, and it adds nothing to semaglutide's pharmacological mechanism. What it does do is fit sensibly into a generally healthy eating pattern, which is what UK clinical guidance from NHS England's weight-management-injections guidance emphasises as part of effective treatment.

If wider questions about nutrition, supplements or skin changes during treatment are on your mind, there is relevant context on our page about Wegovy and skin and on our guide to Mounjaro, semaglutide and Wegovy, both worth reading if you are thinking carefully about what supports the body during treatment, as well as on B12 and Wegovy.

For anyone considering whether Wegovy is the right option, starting with a clinical conversation is the right move. Check your eligibility by beginning a free consultation with our prescribers.